Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

ClinicalTrials.gov ID: NCT04193189

Public ClinicalTrials.gov record NCT04193189. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations of people living with HIV: prior HBV vaccine recipients who are deemed non-responders and individuals who are naïve to HBV vaccination.

Study identification

NCT ID
NCT04193189
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
638 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2020 (Actual)
Primary completion
Aug 13, 2024 (Actual)
Completion
Aug 13, 2024 (Actual)
Last update posted
Jul 20, 2025

2020 – 2024

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Alabama CRS Birmingham Alabama 35222 —
UCLA CARE Center CRS Los Angeles California 90035-4709 —
UCSD Antiviral Research Center San Diego California 92103 —
Ucsf Hiv/Aids Crs San Francisco California 94110 —
Harbor-UCLA CRS Torrance California 90502 —
University of Colorado Hospital CRS Aurora Colorado 80045 —
Whitman-Walker Health CRS Washington D.C. District of Columbia 20005 —
The Ponce de Leon Center CRS Atlanta Georgia 30308-2012 —
Northwestern University CRS Chicago Illinois 60611 —
Johns Hopkins University CRS Baltimore Maryland 21287 —
Massachusetts General Hospital CRS (MGH CRS) Boston Massachusetts 02114 —
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS Boston Massachusetts 02115 —
Washington University Therapeutics (WT) CRS St Louis Missouri 63110-1010 —
New Jersey Medical School Clinical Research Center CRS Newark New Jersey 07103 —
Weill Cornell Chelsea CRS New York New York 10010 —
Columbia P&S CRS New York New York 10032 —
Weill Cornell Uptown CRS New York New York 10065 —
University of Rochester Adult HIV Therapeutic Strategies Network CRS Rochester New York 14642 —
Chapel Hill CRS Chapel Hill North Carolina 27599 —
Greensboro CRS Greensboro North Carolina 27401 —
Cincinnati Clinical Research Site Cincinnati Ohio 45219 —
Case Clinical Research Site Cleveland Ohio 44106 —
Ohio State University CRS Columbus Ohio 43210 —
Penn Therapeutics CRS Philadelphia Pennsylvania 19104 —
University of Pittsburgh CRS Pittsburgh Pennsylvania 15213 —
Vanderbilt Therapeutics (VT) CRS Nashville Tennessee 47183 —
Houston AIDS Research Team CRS Houston Texas 77009 —
University of Washington AIDS CRS Seattle Washington 98104-9929 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04193189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04193189 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →